BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 22270991)

  • 1. No impact of perioperative blood transfusion on recurrence of hepatocellular carcinoma after hepatectomy.
    Kuroda S; Tashiro H; Kobayashi T; Oshita A; Amano H; Ohdan H
    World J Surg; 2012 Mar; 36(3):651-8. PubMed ID: 22270991
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood transfusion is associated with recurrence of hepatocellular carcinoma after hepatectomy in Child-Pugh class A patients.
    Harada N; Shirabe K; Maeda T; Kayashima H; Ishida T; Maehara Y
    World J Surg; 2015 Apr; 39(4):1044-51. PubMed ID: 25446481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis.
    Peng T; Zhao G; Wang L; Wu J; Cui H; Liang Y; Zhou R; Liu Z; Wang Q
    Clin Transl Oncol; 2018 Jun; 20(6):719-728. PubMed ID: 29080121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The influence of perioperative blood transfusion on intrahepatic recurrence after curative resection of hepatocellular carcinoma.
    Makino Y; Yamanoi A; Kimoto T; El-Assal ON; Kohno H; Nagasue N
    Am J Gastroenterol; 2000 May; 95(5):1294-300. PubMed ID: 10811342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative blood transfusion does not influence recurrence-free and overall survivals after curative resection for hepatocellular carcinoma: A Propensity Score Matching Analysis.
    Yang T; Lu JH; Lau WY; Zhang TY; Zhang H; Shen YN; Alshebeeb K; Wu MC; Schwartz M; Shen F
    J Hepatol; 2016 Mar; 64(3):583-93. PubMed ID: 26596543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
    Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
    Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
    [No Abstract]   [Full Text] [Related]  

  • 7. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 8. Perioperative blood transfusion has distinct postsurgical oncologic impact on patients with different stage of hepatocellular carcinoma.
    Chen GX; Qi CY; Hu WJ; Wang XH; Hua YP; Kuang M; Peng BG; Li SQ
    BMC Cancer; 2020 May; 20(1):487. PubMed ID: 32471389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perioperative allogenic blood transfusion is a poor prognostic factor after hepatocellular carcinoma surgery: a multi-center analysis.
    Wada H; Eguchi H; Nagano H; Kubo S; Nakai T; Kaibori M; Hayashi M; Takemura S; Tanaka S; Nakata Y; Matsui K; Ishizaki M; Hirokawa F; Komeda K; Uchiyama K; Kon M; Doki Y; Mori M
    Surg Today; 2018 Jan; 48(1):73-79. PubMed ID: 28597349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perioperative blood transfusion promotes recurrence of hepatocellular carcinoma after hepatectomy.
    Yamamoto J; Kosuge T; Takayama T; Shimada K; Yamasaki S; Ozaki H; Yamaguchi N; Mizuno S; Makuuchi M
    Surgery; 1994 Mar; 115(3):303-9. PubMed ID: 8128355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perioperative blood transfusion in hepatocellular carcinomas: influence of immunologic profile and recurrence free survival.
    Kwon AH; Matsui Y; Kamiyama Y
    Cancer; 2001 Feb; 91(4):771-8. PubMed ID: 11241245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of perioperative allogeneic blood transfusion on prognosis of hepatocellular carcinoma after radical hepatectomy: A systematic review and meta-analysis of cohort studies.
    Xun Y; Tian H; Hu L; Yan P; Yang K; Guo T
    Medicine (Baltimore); 2018 Oct; 97(43):e12911. PubMed ID: 30412094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of antithrombin III levels for outcomes in patients with hepatocellular carcinoma after curative hepatectomy.
    Iwako H; Tashiro H; Amano H; Tanimoto Y; Oshita A; Kobayashi T; Kuroda S; Tazawa H; Nambu J; Mikuriya Y; Abe T; Ohdan H
    Ann Surg Oncol; 2012 Sep; 19(9):2888-96. PubMed ID: 22466667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Negative impact of blood transfusion on recurrence and prognosis of hepatocellular carcinoma after hepatic resection.
    Shiba H; Ishida Y; Wakiyama S; Iida T; Matsumoto M; Sakamoto T; Ito R; Gocho T; Furukawa K; Fujiwara Y; Hirohara S; Misawa T; Yanaga K
    J Gastrointest Surg; 2009 Sep; 13(9):1636-42. PubMed ID: 19582515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative blood transfusion and survival following curative hepatic resection for hepatocellular carcinoma.
    Hanazaki K; Kajikawa S; Shimozawa N; Matsushita A; Machida T; Shimada K; Yazawa K; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2005; 52(62):524-9. PubMed ID: 15816471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perioperative Allogeneic Blood Transfusion Does not Influence Patient Survival After Hepatectomy for Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
    Yamashita YI; Hayashi H; Imai K; Okabe H; Nakagawa S; Kitamura F; Uemura N; Nakao Y; Yusa T; Itoyama R; Yamao T; Umesaki N; Miyata T; Chikamoto A; Shimokawa M; Baba H
    World J Surg; 2019 Nov; 43(11):2894-2901. PubMed ID: 31312946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perioperative blood transfusion as a prognostic indicator in patients with hepatocellular carcinoma.
    Asahara T; Katayama K; Itamoto T; Yano M; Hino H; Okamoto Y; Nakahara H; Dohi K; Moriwaki K; Yuge O
    World J Surg; 1999 Jul; 23(7):676-80. PubMed ID: 10390585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of perioperative allogeneic blood transfusion on the long-term prognosis of patients with different stage tumors after radical resection for hepatocellular carcinoma.
    Peng T; Wang L; Cui H; Li X; Liu M; Yu J; Wu J; Zhao G; Liu Z
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):620-627. PubMed ID: 32988700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of risk factors of recurrence of hepatocellular carcinoma after control of surgical-risk-factors].
    Wang L; Wu F; Wu J; Rong W; Yu W; An S; Liu F; Feng L
    Zhonghua Zhong Liu Za Zhi; 2014 Aug; 36(8):629-34. PubMed ID: 25430033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes following laparoscopic versus open major hepatectomy for hepatocellular carcinoma in patients with cirrhosis: a propensity score-matched analysis.
    Xu HW; Liu F; Li HY; Wei YG; Li B
    Surg Endosc; 2018 Feb; 32(2):712-719. PubMed ID: 28726140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.